Leon Cooperman - Omega Advisors
Holding/activity history for DiaMedica Therapeutics Inc. (DMAC)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 2,020,000 | 0.46 | $6.77 | $13,675,400 | SEC | ||
| 2025 Q4 | 2,020,000 | 0.53 | Reduce 38.22% | 0.21 | $7.96 | $16,079,200 | SEC |
| 2025 Q3 | 3,269,761 | 0.55 | Add 98.17% | 0.27 | $5.40 | $17,644,158 | SEC |
| 2025 Q2 | 1,650,000 | 0.23 | Add 1.54% | <0.01 | $3.90 | $6,435,000 | SEC |
| 2025 Q1 | 1,625,000 | 0.24 | $3.79 | $6,158,750 | SEC | ||
| 2024 Q4 | 1,625,000 | 0.33 | Add 7.49% | 0.02 | $5.43 | $8,823,750 | SEC |
| 2024 Q3 | 1,511,739 | 0.27 | Add 7.98% | 0.02 | $4.19 | $6,334,186 | SEC |
| 2024 Q2 | 1,400,000 | 0.17 | Add 58.44% | 0.06 | $2.95 | $4,130,000 | SEC |
| 2024 Q1 | 883,623 | 0.10 | $2.77 | $2,447,636 | SEC | ||
| 2023 Q4 | 883,623 | 0.12 | Add 0.87% | <0.01 | $2.84 | $2,509,489 | SEC |
| 2023 Q3 | 875,993 | 0.12 | $2.58 | $2,260,062 | SEC | ||
| 2023 Q2 | 875,993 | 0.21 | Add 0.87% | <0.01 | $4.32 | $3,784,290 | SEC |
| 2023 Q1 | 868,413 | 0.08 | Add 6.88% | <0.01 | $1.53 | $1,328,672 | SEC |
| 2022 Q4 | 812,508 | 0.08 | $1.58 | $1,283,844 | SEC | ||
| 2022 Q3 | 812,508 | 0.07 | $1.24 | $1,007,510 | SEC | ||
| 2022 Q2 | 812,508 | 0.11 | $2.02 | $1,641,266 | SEC | ||
| 2022 Q1 | 812,508 | 0.11 | Add 170.84% | 0.07 | $2.50 | $2,031,270 | SEC |
| 2021 Q4 | 300,000 | 0.06 | Add 50.00% | 0.02 | $3.73 | $1,119,000 | SEC |
| 2021 Q3 | 200,000 | 0.04 | Add 300.00% | 0.03 | $4.01 | $802,000 | SEC |
| 2021 Q2 | 50,000 | 0.01 | $4.46 | $223,000 | SEC | ||
| 2021 Q1 | 50,000 | 0.03 | Add 66.67% | 0.01 | $9.16 | $458,000 | SEC |
| 2020 Q4 | 30,000 | 0.02 | Buy | 0.02 | $10.13 | $304,000 | SEC |